These molecules have radically changed the T2D management, as beyond increasing insulin secretion, they retain many other beneficial effects for T2D, including reductions in appetite which may favor body weight loss, lowering glucagon secretion and delaying gastric emptying, reduce inflammation, and, not least, improve cardiovascular health (Table 3). This evidence concerns the gene INS and type 2 diabetes mellitus.